CRESCENT BIOPHARMA, INC. Total Revenue

• CRESCENT BIOPHARMA, INC. showed an increase of +58,516.2% in Total Revenue from 2016 to 2025.
• This data is from CRESCENT BIOPHARMA, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2012 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2013: $3.81 million | Q2 2013: $55.1 thousand | Q3 2013: $52.6 thousand | Q4 2013: $77.4 thousand | Q1 2014: $0.00 | Q2 2014: $15.00 million | Q2 2014: $15.03 million | Q1 2015: $0.00 | Q2 2015: $20.04 million | Q2 2015: $20.00 million | Q4 2015: $35.4 thousand | Q3 2016: $18.5 thousand | Q4 2024: $0.00.
• Over the full 6 years of available data (2012 to 2025), CRESCENT BIOPHARMA, INC.'s Total Revenue has declined by 28.9%.
• Historical annual values: Fiscal year 2025: $10.84 million | Fiscal year 2016: $18.5 thousand | Fiscal year 2015: $20.07 million | Fiscal year 2014: $15.03 million | Fiscal year 2013: $3.99 million | Fiscal year 2012: $15.26 million.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026